HSDT
Solana Company
NASDAQ · Healthcare · Medical - Devices · US
$2.24
−4.68%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$135.43M
MomentumView details →
1D Return
−4.68%
YTD Return
−22.15%
RSI (14)
59.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$135.43M
RSI (14)
59.6
MomentumView details →
1D Return
−4.68%
YTD Return
−22.15%
SummaryUpdated Jun 1, 2026
Helius Medical Technologies, Inc. (NASDAQ:HSDT) is a neurotechnology company founded in 2014 and headquartered in Newtown, Pennsylvania. The company specializes in developing non-invasive medical devices for treating neurological conditions, with its flagship product being the Portable Neuromodulation Stimulator (PoNS). Since going public in 2014, Helius has focused on commercializing its neurostimulation technology for patients suffering from balance and gait deficits caused by multiple sclerosis, traumatic brain injury, and stroke.
Similar companies
Latest newsMore news →
Solana processed a record 5.2 billion non-vote transactions in August 2026, 19% above July, while gross network revenue for H1 2026 fell to $141 million from $1.09 billion a year earlier.2d agoPons generated $4.73 million in fees over 24 hours as of September 1, 2026, surpassing the combined fees of Hyperliquid, Polymarket, and Fomo ($4.65 million) and the combined network fees of Robinhood Chain, BNB Smart Chain, and Solana ($3.46 million).3d ago